Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients

Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients

The development of well-tolerated and effective therapies that target the pathogenesis of membranous nephropathy (MN) would be useful. Our objective was to evaluate the efficacy of rituximab in MN. We analyzed the outcome of 28 patients treated with rituximab for idiopathic MN. Anti-PLA2R antibodies...

Full description

Bibliographic Details
Main Authors: Pierre-Antoine Michel, Karine Dahan, Pierre-Yves Ancel, Emmanuelle Plaisier, Rachid Mojaat, Sophie De Seigneux, Eric Daugas, Marie Matignon, Laurent Mesnard, Alexandre Karras, Hélène François, Agathe Pardon, Valérie Caudwell, Hanna Debiec, Pierre Ronco
Format: Article
Language:English
Published: Karger Publishers 2011-12-01
Series:Nephron Extra
Subjects:
Membranous nephropathy
Proteinuria
Renal failure
Rituximab
Online Access:http://www.karger.com/Article/FullText/333068

Internet

http://www.karger.com/Article/FullText/333068

Similar Items